|
GZF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.43189999985461E-07 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.717600E-03 |
| Stage1-vs-Stage3 |
6.066300E-02 |
| Stage1-vs-Stage4 |
2.366500E-02 |
| Stage2-vs-Stage3 |
1.232240E-04 |
| Stage2-vs-Stage4 |
8.23200000000801E-05 |
| Stage3-vs-Stage4 |
5.207600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.60399998733385E-09 |
| Normal-vs-Asian |
1.75071068753141E-12 |
| Caucasian-vs-AfricanAmerican |
4.097800E-01 |
| Caucasian-vs-Asian |
4.078200E-01 |
| AfricanAmerican-vs-Asian |
8.619400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.016400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(81-100Yrs) |
2.383400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.567200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.404200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.577200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.184800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.546800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.587400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.55269999999797E-05 |
| Classical-VS-Follicular |
4.35429999945391E-07 |
| Classical-VS-Other |
9.445200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
9.03732644275124E-12 |
| Tall-VS-Other |
3.671800E-02 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
1.234780E-01 |
| Follicular-VS-Normal |
2.50430000003909E-06 |
| Other-VS-Normal |
7.75940000000697E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.52650000000621E-05 |
|
|
